Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Exelixis Q3 Adj. EPS $0.78 Beats $0.61 Estimate, Sales $597.755M Beat $589.770M Estimate

Author: Benzinga Newsdesk | November 04, 2025 04:06pm
Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.61 by 27.24 percent. This is a 65.96 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $597.755 million which beat the analyst consensus estimate of $589.770 million by 1.35 percent. This is a 10.79 percent increase over sales of $539.542 million the same period last year.

Posted In: EXEL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist